|
Post by twibs66 on Apr 2, 2014 19:13:06 GMT -5
i am new to the board & have been invested in mannkind since the first crl. i was on metese live blog yesterday & recall something being said about the fda changing a number
from .4 to .3 can someone explain to me what that was all about -tia
|
|
|
Post by liane on Apr 3, 2014 4:37:22 GMT -5
i am new to the board & have been invested in mannkind since the first crl. i was on metese live blog yesterday & recall something being said about the fda changing a number from .4 to .3 can someone explain to me what that was all about -tia twibs, Not exactly sure what you mean. I'm thinking either you are referring to the proposed dosing conversion going from SQ insulin to Afrezza or the confidence intervals in the 171 study that demonstrate non-inferiority.
|
|
|
Post by twibs66 on Apr 3, 2014 19:32:48 GMT -5
thanks Liane for responding it could have been that, matese said the panel was questioning why they (fda) changed the set guideline from .4 to .3 thats all i can remember. oh well doesny really matter at this point.
|
|